arrow
返回
C

Craig Johnstone

GlaxoSmithKline

24H指数
74论文数
2.2K被引数
收录论文 14
发表时间
Identification of CD73 and A2AR/CD73 small molecule inhibitors for cancer immunotherapy as single agents or in combination with Immune-checkpoint therapies
err2019-07-01
err0
PREAI
errFons, Pierre; Bell, Andrew; Esquerre, Michael; Versluys, Stephanie; Bertrand, Florie; Schreyer, Adrian; Hopkins-Navratilova, Iva; Hernani, Leonardo-Silvestre; Bergeaud, Celia; Poussereau-Pomie, Celine; Marchand, Ghislaine; Robinson, Sean; Culurgioni, Simone; Cox, Richard; Besnard, Jeremy; Payne, Andrew; Ray, Peter; Pelissier, Emilie; Paillasse, Michael; Lisztwan, Joanna; Johnstone, Craig; Whittaker, Mark; Hopkins, Andrew
err分享
err收藏
EVOEXS21546 is a novel non-brain penetrant A2AR inhibitor for cancer immunotherapy with accelerated drug development
err2019-07-01
err1
PREAI
errFons, Pierre; Bell, Andy; Esquerre, Michael; Versluys, Stephanie; Bertrand, Florie; Hopkins-Navratilova, Iva; Robinson, Sean; Visentin, Virgile; Schreyer, Adrian; Cox, Richard; Mirey, Emilie; Pelissier, Emilie; Bergeaud, Celia; Culurgioni, Simone; Besnard, Jeremy; Payne, Andrew; Menegotto, Jerome; Machet, Frederic; Poussereau-Pomie, Celine; Cogo, Eric; Paillasse, Michael; Ferigo, Federica; Pagliarusco, Sabrina; Lisztwan, Joanna; Whittaker, Mark; Johnstone, Craig; Hopkins, Andrew
err分享
err收藏
Identification of a novel non-brain penetrant A2AR inhibitor and proof-of-concept of CD73 and A2AR/CD73 small-molecule inhibitors for cancer immunotherapy
err2018-07-01
err2
PREAI
errFons, Pierre; Bell, Andy; Esquerre, Michael; Versluys, Stephanie; Bertrand, Florie; Poussereau-Pomie, Celine; Schreyer, Adrian; Cox, Richard; Besnard, Jeremy; Paillasse, Michael; Swindells, Mark; Lisztwan, Joanna; Johnstone, Craig; Whittaker, Mark; Hopkins, Andrew
err分享
err收藏
Targeting the adenosine immunosuppressive pathway for cancer immunotherapy with small molecule agents
err2017-07-01
err3
PREAI
errFons, Pierre; Esquerre, Michael; Versluys, Stephanie; Mambrini, Gigliola; Paillasse, Michael; Bell, Andy; Schreyer, Adrian; Cox, Richard; Bickerton, Richard; Lisztwan, Joanna; Whittaker, Mark; Bono, Francoise; Johnstone, Craig; Hopkins, Andrew
err分享
err收藏
Designed multiple ligands in metabolic disease research: from concept to platform
err2013-08-01
err17
PREAI
errGattrell, W.; Johnstone, C.; Patel, S.; Smith, C. Sambrook; Scheel, A.; Schindler, M.
err分享
err收藏
Hypothesis driven drug design: improving quality and effectiveness of the design-make-test-analyse cycle
err2012-01-01
err67
PREAI
errPlowright, Alleyn T.; Johnstone, Craig; Kihlberg, Jan; Pettersson, Jonas; Robb, Graeme; Thompson, Richard A.
err分享
err收藏
Making medicinal chemistry more effective-application of Lean Sigma to improve processes, speed and quality
err2009-06-01
err60
PREAI
errAndersson, Shalini; Armstrong, Alan; Bjore, Annika; Bowker, Sue; Chapman, Steve; Davies, Rob; Donald, Craig; Egner, Bryan; Elebring, Thomas; Holmqvist, Sara; Inghardt, Tord; Johannesson, Petra; Johansson, Magnus; Johnstone, Craig; Kemmitt, Paul; Kihlberg, Jan; Korsgren, Pernilla; Lemurell, Malin; Moore, Jane; Pettersson, Jonas A.; Pointon, Helen; Ponten, Fritiof; Schofield, Paul; Selmi, Nidhal; Whittamore, Paul
err分享
err收藏
Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats
err2009-01-29
err81
errOAAI
errCoope, G. J.; Atkinson, A. M.; Allott, C.; McKerrecher, D.; Johnstone, C.; Pike, K. G.; Holme, P. C.; Vertigan, H.; Gill, D.; Coghlan, M. P.; Leighton, B.
err分享
err收藏
A new approach to functionalised spiropiperidines through tandem RCM and nitrogen-directed reactions
err2002-06-18
err46
PREAI
errEdwards, AS; Wybrow, RAJ; Johnstone, C; Adams, H; Harrity, JPA
err分享
err收藏
Novel 4-anilinoquinazolines with C-7 basic side chains:: Design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors
err2002-02-19
err374
PREAI
errHennequin, LF; Stokes, ESE; Thomas, AP; Johnstone, C; Plé, PA; Ogilvie, DJ; Dukes, M; Wedge, SR; Kendrew, J; Curwen, JO
err分享
err收藏
Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors
err1999-12-10
err331
PREAI
errHennequin, LF; Thomas, AP; Johnstone, C; Stokes, ESE; Plé, PA; Lohmann, JJM; Ogilvie, DJ; Dukes, M; Wedge, SR; Curwen, JO; Kendrew, J; Lambert-van der Brempt, C
err分享
err收藏